- Zacks•7 hours ago
Allergan Plc (AGN) and European specialty pharma company Gedeon Richter reported encouraging results from a phase III study on their pipeline candidate, ulipristal acetate, in women with abnormal bleeding due to uterine fibroids.
- TheStreet.com•16 hours ago
The pharmaceutical company's new strategy emphasizes new product launches and international expansion.
- Reuters•23 hours ago
The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - President Barack Obama shortened Chelsea Manning's 35-year ...
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||214.70 - 219.13|
|52 Week Range||184.50 - 301.98|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.07|
|Dividend & Yield||2.80 (1.30%)|
|1y Target Est||N/A|